Have you investigated the presence of decabromodiphenyl ether (DBD) in your product? Did your previous tests show that the sum of DBD and 1-9 bromodiphenyl ethers exceeded 1000 ppm? Are you aware that from July 1, 2008, a product exceeding 1000 ppm of the sum of DBD and 1-9 bromodiphenyl ethers would be non-compliant with EU RoHS? Please act immediately to conduct an assessment, as the EU will remove the DBD exemption on July 1, 2008. On April 1, 2008, the European Court of Justice issued a notice stating that the European Commission had violated relevant regulations in exercising its powers regarding the DBD exemption in Directive 2005/717/EC, and therefore removed the DBD exemption from the RoHS Directive. However, considering the need for a transition period, the European Court of Justice allowed the DBD exemption to be extended until June 30, 2008. Previously, the European Commission adopted RoHS Directive 2002/95/EC, Article 10 of the Annex: "The European Commission shall evaluate the application of decabromodiphenyl ether in accordance with the procedure referred to in Article 7(2)...". Subsequently, the risk assessment of decabromodiphenyl ether was undertaken by the UK and France, with the UK responsible for assessing its environmental impact and France for assessing its human health impact. The UK completed its first assessment report in May 2004, and in August 2005, the UK published an addendum to the 2004 risk assessment report. On October 13, 2005, the European Commission published Directive 2005/717/EC, Article 2 of the Annex...
